Loading clinical trials...
Loading clinical trials...
Defining a Noninvasive Signature for Pulmonary Vascular Remodeling in Group 3 PH
Conditions
Interventions
Hyperpolarized 129Xe
Locations
1
United States
Duke University Medical Center
Durham, North Carolina, United States
Start Date
November 8, 2023
Primary Completion Date
July 31, 2027
Completion Date
July 31, 2028
Last Updated
February 24, 2026
NCT05746039
NCT07383896
NCT06329401
NCT07509606
NCT07484243
NCT07477600
Lead Sponsor
Bastiaan Driehuys
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions